• It is the responsibility of both parties (the previous manufacturer and new manufacturer) to complete an NDC Transfer form in its entirety and submit it to dha.ncr.healthcare-ops.mbx.ufvarr-requests@health.mil. The form must contain the signatures of both parties. Once the TRICARE Retail Refund Team (TRRT) receives, reviews, and approves the form, billing can be updated. Please note that if the form is submitted with transfer dates in a previous quarter, the transfer will be reflected in the upcoming billing quarter.
• If a pharmaceutical agent being transferred has an active ADP Agreement in place, contact DHA Contracting or the DHA Industry Technical Liaison via Email.

It is not necessary to notify the TRRP. The TRRP uses the discontinuation date of the last lot produced, according to information provided by Centers for Medicare and Medicaid Services (CMS), plus 365 days to determine an NDC’s last day for refund billing. 

If an NDC is reported to the TRRT with a positive minimum refund, it is a covered drug under 38 U.S.C. 8126 of the final rule and eligible for the TRICARE Retail Refund Program. A refund will be owed for covered drugs dispensed through pharmacies identified as part of the TRICARE Retail Network, which includes long term care facilities, specialty pharmacies, and pharmacies inside physician offices or hospitals. In the event that an NDC appears to be incorrectly reported to TRICARE as a covered drug, please contact your POC at the Department of Veterans Affairs. The manufacturer may also submit disputes for these claims (please see the Dispute Submission process in the TRICARE Retail Refund Program Process & Procedures Guide) so that proper credit can be given in the event that the disputes are accepted.

Although Section 703 Compliant, there are many reasons as to why a drug may not be covered under TRICARE formulary. All formulary questions should be directed to the DHA Industry Technical Liaison via Email.

All ADP Agreements for drugs belonging to drug classes reviewed in Pharmaceutical & Therapeutics Committee Meetings will be terminated upon the effective dates determined within the review of each class, regardless of formulary standing. However, if a drug is designated non-formulary per the P&T Committee, a bid that may have been submitted for consideration will not be accepted. ADP Agreements to be terminated will be done so with a termination date determined within each class (not the signing of the minutes unless otherwise indicated). Please refer to the P&T Committee Meeting Minutes for more information.

• If an NDC is not included on an ADP Agreement and the pharmaceutical agent is the same for the NDC(s) for which an ADP Agreement is in place, it will be referred to DHA Contracting for review and decision.
• Typically, WAC ADP Agreements will include drugs that are not Covered Drugs, such as diabetes testing supplies. If the NDC is not included on the WAC ADP Agreement for a non-Covered Drug, it will not be billed under WAC, ADP, or SDP. If the NDC of the pharmaceutical agent on the ADP Agreement is a Covered Drug, then it will be billed ADP (FCP or WAC based on the ADP Agreement in place)
• Please refer further questions to DHA Contracting or the DHA Industry Technical Liaison via Email.

Yes. Examples include; duplicate inhalers for school and home, vacation supplies, lost medication, or provider prescribed increased dosages. It is important to take this into consideration when disputing utilization data.

DHA requires that a Manufacturer TRICARE Retail Refund 340b Verification Form be completed by the pharmacy to validate that a prescription was dispensed with 340b product prior to accepting these disputes. Please refer to the Manufacturer Policy and Procedure guide for more information regarding K Codes.

The 340b Verification Form can be found on our Information for Pharmaceutical Manufacturers page under Operational Documents.

TRICARE retail pharmacy includes long term care facilities, specialty pharmacies, pharmacies inside a physician's office and hospital, and all other pharmacies identified as part of the TRICARE Retail Network. Please refer to the Manufacturer Policy and Procedure guide available on the Information for Pharmaceutical Manufacturers page under Operational Documents for more information regarding pharmacy eligibility.

• TRRWS accounts are used to maintain up-to-date Manufacturer contact information, to identify appropriate point of contact (POC) and provide them with secure access to TRICARE Retail Refund Program data; as well as delivery of program correspondence and quarterly utilization data. All Manufacturers must maintain up to date contact information using the Manufacturer Questionnaire within TRRWS.
• To view and retrieve TRICARE Retail Refund Program data directly from the TRRWS.

• All manufacturer POCs should maintain an active account on TRRWS.

• There can only be 3 POCs assigned per Labeler (1 Primary and 2 Alternate POCs).
• Manufacturers will provide Primary and Alternate POCs as well as any changes or updates that have occurred to the contact information in a timely manner to maintain access to Manufacturer data.
• Third-party consultants may not be listed as the Primary POC.
• Only Manufacturer POCs currently assigned to labelers within TRRWS will be able to retrieve or discuss a Manufacturers’ proprietary information with the TRICARE Retail Refund Team (TRRT).
• Note: Effective July 2020, any Manufacturer/Third Party Shared or Group Emails will NOT be allowed to be listed as a POC on the TRRWS.

Follow these steps:

1. Go to TRRWS (https://trrws.health.mil/Public/Login.aspx).
2. Select the “Request New User Account” link and complete the form. 
3. A TRRT member will review and process your request for access. 
4. You may only request one (1) labeler for initial login; additional labeler requests may be submitted once your access to the site has been approved.

For more information please refer to the TRRWS Manufacturer User Guide located on our Information for Pharmaceutical Manufacturers page under Operational Documents.

Follow these steps:

1. Log into the TRRWS.
2. Click “Request Labeler Access”.
3. Request labeler access on TRRWS by submitting the six digit labeler code of your requested Manufacturer including the alpha character (X#####).  
4. An email will be sent to the assigned Primary POC and to the TRRT for review. 
5. You will receive an email when your access has been approved

Please see the TRRWS Manufacturer User Guide located on the Information for Pharmaceutical Manufacturers page under Operational Documents for additional details. 

• A notification email will be sent from TRRWS Support (dha.ncr.j-3.mbx.trrws-it-support@health.mil).
• TRRP correspondence will only be sent to the Manufacturer POCs currently assigned on TRRWS.
•  For more information regarding the billing schedule please refer to the Information on the Pharmaceutical Manufacturers Page.

Report Issue with the TRRWS Website